Although our findings in HFpEF lungs provide insights into the molecular mechanisms linking HFpEF and COPD, further studies using COPD models are needed to fully elucidate the shared pathogenic mechanisms and validate SESN3 as a therapeutic target. The gene discussed is SESN3; the disease is chronic obstructive pulmonary disease.